Focusing on suppression of IBD by controlling the IL-1 signaling involved in the exacerbation of inflammation, we constructed a gmLAB that secretes rmIL-1Ra and investigated its efficacy using an acute colitis model. This evidence concerns the gene IL1B and colitis.